Age at menarche relates to depression in adolescent girls: Comparing a clinical sample to the general pediatric population.


Journal

Journal of affective disorders
ISSN: 1573-2517
Titre abrégé: J Affect Disord
Pays: Netherlands
ID NLM: 7906073

Informations de publication

Date de publication:
01 12 2022
Historique:
received: 27 03 2022
revised: 23 08 2022
accepted: 25 08 2022
pubmed: 5 9 2022
medline: 30 9 2022
entrez: 4 9 2022
Statut: ppublish

Résumé

The timing of puberty, physical features of pubertal development, and hormones are closely intertwined but may also individually contribute to the risk for depression and depression severity. Additionally, their effects on mood may depend on depression severity, but previously this has only been studied in mostly subclinical depression. In 184 girls from a single psychiatric hospital with significant depressive symptoms (Beck Depression Inventory-II score > 13), the relationship between depression severity and age at menarche (AAM), pubertal status, and gonadal/adrenal hormones (estradiol, progesterone, DHEA-S, androstenedione, testosterone, dihydrotestosterone) was investigated. Moreover, AAM in depressed girls was compared to that from a representative sample of German adolescents without a psychiatric disorder (N = 1674). Androgen levels were compared to those of age- and sex-matched controls (N = 59). AAM but not pubertal stage or biochemical parameters related to depression. Girls with AAM at the lower normative range of pubertal development were 61 % more likely to develop depression and scored 4.9 points higher on the depression scale than girls experiencing menarche at the population average. Androstenedione levels were increased in the psychiatric sample, but neither androgen nor gonadal hormone levels were associated with depression severity. The study is cross-sectional. These observations confirm previous studies in mostly subclinical depression and highlight the importance of AAM for adolescent depression. Thus, AAM could be considered a prognostic factor for a clinical risk score assessing the probability of adolescent depression. Moreover, these findings suggest fostering efforts that address risk factors that contribute to an earlier AAM.

Identifiants

pubmed: 36058357
pii: S0165-0327(22)00948-X
doi: 10.1016/j.jad.2022.08.092
pii:
doi:

Substances chimiques

Androgens 0
Dihydrotestosterone 08J2K08A3Y
Testosterone 3XMK78S47O
Androstenedione 409J2J96VR
Progesterone 4G7DS2Q64Y
Estradiol 4TI98Z838E
Dehydroepiandrosterone Sulfate 57B09Q7FJR

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

103-112

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of Interest The authors declare no conflicts of interest.

Auteurs

Raphael Hirtz (R)

Division of Pediatric Endocrinology and Diabetology, Department of Pediatrics II, University Hospital Essen, University of Duisburg-Essen, Hufelandstr 55, 40211 Essen, Germany; Department of Child and Adolescent Psychiatry and Psychotherapy, University Hospital Essen, University of Duisburg-Essen, Wickenburgstr 21, 40211 Essen, Germany. Electronic address: raphael.hirtz@uk-essen.de.

Lars Libuda (L)

Institute of Nutrition, Consumption and Health, Faculty of Natural Sciences, University Paderborn, Warbuger Str. 100, 33098 Paderborn, Germany.

Anke Hinney (A)

Department of Child and Adolescent Psychiatry and Psychotherapy, University Hospital Essen, University of Duisburg-Essen, Wickenburgstr 21, 40211 Essen, Germany.

Manuel Föcker (M)

Department of Child and Adolescent Psychiatry, University Hospital Münster, Schmeddingstr 50, 48149 Münster, Germany.

Judith Bühlmeier (J)

Department of Child and Adolescent Psychiatry and Psychotherapy, University Hospital Essen, University of Duisburg-Essen, Wickenburgstr 21, 40211 Essen, Germany.

Paul-Martin Holterhus (PM)

Department of Pediatrics I, Pediatric Endocrinology and Diabetes, University Hospital of Schleswig-Holstein, UKSH, Campus Kiel, and Christian-Albrechts University, Arnold-Heller-Str. 3, 24105 Kiel, Germany.

Alexandra Kulle (A)

Department of Pediatrics I, Pediatric Endocrinology and Diabetes, University Hospital of Schleswig-Holstein, UKSH, Campus Kiel, and Christian-Albrechts University, Arnold-Heller-Str. 3, 24105 Kiel, Germany.

Cordula Kiewert (C)

Division of Pediatric Endocrinology and Diabetology, Department of Pediatrics II, University Hospital Essen, University of Duisburg-Essen, Hufelandstr 55, 40211 Essen, Germany.

Ronny Kuhnert (R)

Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany, General-Pape-Str. 62-66, 12101 Berlin.

Caroline Cohrdes (C)

Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany, General-Pape-Str. 62-66, 12101 Berlin.

Triinu Peters (T)

Department of Child and Adolescent Psychiatry and Psychotherapy, University Hospital Essen, University of Duisburg-Essen, Wickenburgstr 21, 40211 Essen, Germany.

Johannes Hebebrand (J)

Department of Child and Adolescent Psychiatry and Psychotherapy, University Hospital Essen, University of Duisburg-Essen, Wickenburgstr 21, 40211 Essen, Germany.

Corinna Grasemann (C)

Department of Pediatrics, Division of Rare Diseases and CeSER, St. Josef-Hospital, Ruhr-University Bochum, Alexandrinenstr 5, 44791 Bochum, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH